Article
Published 30 Jun 2025
China Compliance Update: Life Sciences — Summer 2025
Arnold & Porter
Your search returned 182 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 29 Jun 2025
Growth and Opportunities in China's Medical Device Market.
Acclime
Article
Published 25 Jun 2025
中国创新药械全球崛起法律保障系列文章之一：创新药研发企业临床试验数据对外跨境传输的监管要点
AnJie Broad Law Firm
Article
Published 11 Jun 2025
试管婴儿辅助生殖行业法律问题探究
AnJie Broad Law Firm
Article
Published 14 May 2025
China Advances Pharmaceutical Data Protection Regime With New Draft Measures
A&O Shearman
Article
Published 3 Apr 2025
里程碑式判决：经营者集中行政诉讼"第一案"代理有感
AnJie Broad Law Firm
Article
Published 2 Apr 2025
Safeguards Of Dapagliflozin's Half Billion USD Sales In China: AstraZeneca
Rouse
Article
Published 28 Feb 2025
China Newsletter | Q4 2024/Issue No. 62
Greenberg Traurig, LLP
Article
Published 6 Feb 2025
China Unveils New Anti-Monopoly Guidelines For The Pharmaceutical Sector
Jones Day
Article
Published 29 Jan 2025
China Life Sciences: 2024 Year In Review
Arnold & Porter
Article
Published 28 Jan 2025
China Tightens The Reins: Anti-Corruption Compliance Expectations For Companies In The Healthcare Sector
Ropes & Gray LLP
Article
Published 23 Jan 2025
Chinese Regulators Publish Final Anti-Corruption Guidelines For The Healthcare Industry
Arnold & Porter
Article
Published 9 Jan 2025
China Announces Major Policy Incentives For Life Sciences Companies
Ropes & Gray LLP
Article
Published 10 Dec 2024
China's New Draft Administrative Measures For Management Of Medical Representatives
Arnold & Porter
Article
Published 5 Dec 2024
The New Draft Administrative Measures For Management Of Medical Representatives
Arnold & Porter
Article
Published 28 Nov 2024
中国在医疗和生物技术领域的外资新政策：推动创新发展与加强专利保护
Lusheng Law Firm
Article
Published 27 Nov 2024
Relaxation Of Long-Standing Restrictions On Foreign Investment In The Healthcare Sector In China
McDermott Will & Emery
Article
Published 5 Nov 2024
Landmark Whistleblower Program For China's Healthcare Sector
Arnold & Porter
Article
Published 4 Nov 2024
Landmark Whistleblower Program For China's Healthcare Sector: Proposed Maximum Reward Of 1 Million RMB
Arnold & Porter
Article
Published 30 Oct 2024
干细胞与基因治疗领域扩大开放新政及CAR-T地方监管新规初探
AnJie Broad Law Firm